杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/05 | 1,680 | 1,680 | 1,667 | 1,671 | -12 | -0.7% | 72,100 |
| 2023/01/04 | 1,712 | 1,713 | 1,683 | 1,683 | -37 | -2.2% | 65,400 |
| 2022/12/30 | 1,720 | 1,733 | 1,719 | 1,720 | -3 | -0.2% | 27,700 |
| 2022/12/29 | 1,700 | 1,726 | 1,699 | 1,723 | +16 | +0.9% | 68,800 |
| 2022/12/28 | 1,704 | 1,708 | 1,701 | 1,707 | -1 | -0.1% | 36,800 |
| 2022/12/27 | 1,712 | 1,721 | 1,705 | 1,708 | -3 | -0.2% | 29,800 |
| 2022/12/26 | 1,716 | 1,717 | 1,706 | 1,711 | -8 | -0.5% | 24,300 |
| 2022/12/23 | 1,724 | 1,731 | 1,714 | 1,719 | +1 | +0.1% | 60,300 |
| 2022/12/22 | 1,702 | 1,720 | 1,700 | 1,718 | +7 | +0.4% | 41,400 |
| 2022/12/21 | 1,712 | 1,721 | 1,696 | 1,711 | -8 | -0.5% | 81,000 |
| 2022/12/20 | 1,737 | 1,742 | 1,707 | 1,719 | -13 | -0.8% | 76,100 |
| 2022/12/19 | 1,714 | 1,738 | 1,714 | 1,732 | +17 | +1% | 40,000 |
| 2022/12/16 | 1,735 | 1,744 | 1,715 | 1,715 | -31 | -1.8% | 170,400 |
| 2022/12/15 | 1,759 | 1,761 | 1,746 | 1,746 | -13 | -0.7% | 51,600 |
| 2022/12/14 | 1,755 | 1,771 | 1,750 | 1,759 | +12 | +0.7% | 89,300 |
| 2022/12/13 | 1,743 | 1,750 | 1,734 | 1,747 | +18 | +1% | 67,800 |
| 2022/12/12 | 1,736 | 1,739 | 1,725 | 1,729 | -17 | -1% | 40,400 |
| 2022/12/09 | 1,746 | 1,749 | 1,725 | 1,746 | +3 | +0.2% | 144,100 |
| 2022/12/08 | 1,751 | 1,754 | 1,723 | 1,743 | -5 | -0.3% | 89,500 |
| 2022/12/07 | 1,720 | 1,754 | 1,718 | 1,748 | +20 | +1.2% | 87,500 |
| 2022/12/06 | 1,717 | 1,736 | 1,717 | 1,728 | -5 | -0.3% | 76,500 |
| 2022/12/05 | 1,740 | 1,740 | 1,717 | 1,733 | -13 | -0.7% | 80,300 |
| 2022/12/02 | 1,752 | 1,761 | 1,729 | 1,746 | -21 | -1.2% | 92,100 |
| 2022/12/01 | 1,782 | 1,782 | 1,754 | 1,767 | -3 | -0.2% | 60,900 |
| 2022/11/30 | 1,776 | 1,792 | 1,767 | 1,770 | -28 | -1.6% | 97,700 |
| 2022/11/29 | 1,830 | 1,830 | 1,793 | 1,798 | -46 | -2.5% | 84,700 |
| 2022/11/28 | 1,873 | 1,873 | 1,837 | 1,844 | -35 | -1.9% | 62,100 |
| 2022/11/25 | 1,879 | 1,883 | 1,862 | 1,879 | +17 | +0.9% | 64,800 |
| 2022/11/24 | 1,846 | 1,868 | 1,841 | 1,862 | -5 | -0.3% | 102,700 |
| 2022/11/22 | 1,850 | 1,869 | 1,850 | 1,867 | +25 | +1.4% | 83,300 |
| 2022/11/21 | 1,837 | 1,846 | 1,832 | 1,842 | +5 | +0.3% | 46,300 |
| 2022/11/18 | 1,823 | 1,840 | 1,793 | 1,837 | +32 | +1.8% | 69,300 |
| 2022/11/17 | 1,780 | 1,805 | 1,780 | 1,805 | +29 | +1.6% | 47,700 |
| 2022/11/16 | 1,779 | 1,789 | 1,774 | 1,776 | +1 | +0.1% | 37,800 |
| 2022/11/15 | 1,770 | 1,793 | 1,762 | 1,775 | +13 | +0.7% | 54,700 |
| 2022/11/14 | 1,771 | 1,775 | 1,755 | 1,762 | -9 | -0.5% | 39,000 |
| 2022/11/11 | 1,782 | 1,789 | 1,754 | 1,771 | +29 | +1.7% | 108,400 |
| 2022/11/10 | 1,738 | 1,743 | 1,712 | 1,742 | -44 | -2.5% | 189,600 |
| 2022/11/09 | 1,789 | 1,793 | 1,777 | 1,786 | ±0 | ±0% | 39,200 |
| 2022/11/08 | 1,773 | 1,794 | 1,768 | 1,786 | +16 | +0.9% | 50,500 |
| 2022/11/07 | 1,771 | 1,782 | 1,760 | 1,770 | +4 | +0.2% | 53,000 |
| 2022/11/04 | 1,790 | 1,790 | 1,758 | 1,766 | -49 | -2.7% | 92,300 |
| 2022/11/02 | 1,811 | 1,824 | 1,798 | 1,815 | +6 | +0.3% | 106,400 |
| 2022/11/01 | 1,840 | 1,845 | 1,805 | 1,809 | -30 | -1.6% | 32,100 |
| 2022/10/31 | 1,811 | 1,844 | 1,811 | 1,839 | +36 | +2% | 65,200 |
| 2022/10/28 | 1,790 | 1,817 | 1,784 | 1,803 | +4 | +0.2% | 314,300 |
| 2022/10/27 | 1,803 | 1,813 | 1,787 | 1,799 | -5 | -0.3% | 51,300 |
| 2022/10/26 | 1,783 | 1,811 | 1,781 | 1,804 | +31 | +1.7% | 54,300 |
| 2022/10/25 | 1,776 | 1,782 | 1,764 | 1,773 | +8 | +0.5% | 85,200 |
| 2022/10/24 | 1,781 | 1,783 | 1,761 | 1,765 | -14 | -0.8% | 74,600 |
551～
600
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 143,100円 | +3.2% | +4.5% | 3.63% | 16.44倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 持田薬 | 301,500円 | +3.0% | +27.5% | 2.65% | 19.09倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 174,100円 | +21.7% | +999.9% | 0.00% | 7.25倍 | 2.40倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 栄研化 | 213,600円 | +0.4% | -8.4% | 2.48% | 27.42倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
